Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / American Depositary Shares, each representing 6 Ordinary Shares
-
Shares outstanding
-
1,571,428,571
-
Total 13F shares
-
143,571,040
-
Share change
-
-4,772,011
-
Total reported value
-
$113,849,906
-
Price per share
-
$0.79
-
Number of holders
-
76
-
Value change
-
-$3,752,852
-
Number of buys
-
24
-
Number of sells
-
38
Institutional Holders of ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY) as of Q4 2023
As of 31 Dec 2023,
ADAPTIMMUNE THERAPEUTICS PLC - American Depositary Shares, each representing 6 Ordinary Shares (ADAPY) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
143,571,040 shares.
The largest 10 holders included
Matrix Capital Management Company, LP, NEA Management Company, LLC, BAILLIE GIFFORD & CO, Long Focus Capital Management, LLC, BAKER BROS. ADVISORS LP, PFM Health Sciences, LP, MPM ASSET MANAGEMENT LLC, MPM BioImpact LLC, BANK OF AMERICA CORP /DE/, and TANG CAPITAL MANAGEMENT LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.